• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

High-resolution structure of the Influenza A virus PB2cap binding domain illuminates the changes induced by ligand binding

tetano

Editor, Senior Moderator
Acta Crystallogr F Struct Biol Commun. 2018 Mar 1;74(Pt 3):122-127. doi: 10.1107/S2053230X18000894. Epub 2018 Feb 26.
[h=1]High-resolution structure of the Influenza A virus PB2cap binding domain illuminates the changes induced by ligand binding.[/h] Constantinides A[SUP]1[/SUP], Gumpper R[SUP]1[/SUP], Severin C[SUP]1[/SUP], Luo M[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] In the face of increasing drug resistance and the rapidly increasing necessity for practicality in clinical settings, drugs targeting different viral proteins are needed in order to control influenza A and B. A small molecule that tenaciously adheres to the PB2cap binding domain, part of the heterotrimeric RNA polymerase machinery of influenza A virus and influenza B virus, is a promising drug candidate. Understanding the anatomic behavior of PB2cap upon ligand binding will aid in the development of a more robust inhibitor. In this report, the anatomic behavior of the influenza A virus PB2cap domain is established by solving the crystal structure of native influenza A virus PB2cap at 1.52 ? resolution. By comparing it with the ligand-bound structure, the dissociation and rotation of the ligand-binding domain in PB2cap from the C-terminal domain is identified. This domain movement is present in many PB2cap structures, suggesting its functional relevance for polymerase activity.


[h=4]KEYWORDS:[/h] Influenza A virus; RNA polymerase; cap-snatching; domain movement; high resolution structures; polymerase basic protein 2; transcription

PMID: 29497014 DOI: 10.1107/S2053230X18000894
 
Back
Top